In this episode of Deeptech Talk, Riya Gupta, research analyst for healthcare at BIS Research, is joined by Sidharth Ananthnarayan, clinical research professional with experience in clinical trial execution and cell therapy operations for multiple sclerosis & hematology-oncology indications.

In conversation with Riya, Sidharth shares his experience and views on the current state of multi-cancer screening techniques and how is it expected to evolve the overall healthcare segment.

BIS Research has recently released an extensive market study on the Multi Cancer Screening Market. You can visit our website to get a FREE sample report.

Additionally, you can schedule a call with one of our experts to learn about the latest market updates in your respective industry vertical.